So far the protein level of S100A8 has been studied by immunohistochemistry and shown to be up-regulated in colorectal carcinoma, lung cancer, pancreatic cancer, breast cancer and thyroid carcinoma [23–30]. Here, S100A8 is linked to familial pancreatic carcinoma.